737 related articles for article (PubMed ID: 15448003)
21. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
[TBL] [Abstract][Full Text] [Related]
22. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
23. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
Bevilacqua RA; Simpson AJ
Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
[TBL] [Abstract][Full Text] [Related]
25. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
26. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
[TBL] [Abstract][Full Text] [Related]
27. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
28. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines.
Yao Y; Tao H; Kim JJ; Burkhead B; Carloni E; Gasbarrini A; Sepulveda AR
Lab Invest; 2004 Jul; 84(7):915-22. PubMed ID: 15133479
[TBL] [Abstract][Full Text] [Related]
29. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
30. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.
Wijnen J; Khan PM; Vasen H; van der Klift H; Mulder A; van Leeuwen-Cornelisse I; Bakker B; Losekoot M; Møller P; Fodde R
Am J Hum Genet; 1997 Aug; 61(2):329-35. PubMed ID: 9311737
[TBL] [Abstract][Full Text] [Related]
31. Mismatch repair deficiency in sporadic synchronous colorectal cancer.
Brueckl WM; Limmert T; Brabletz T; Guenther K; Jung A; Hermann K; Wiest GH; Kirchner T; Hohenberger W; Hahn EG; Wein A
Anticancer Res; 2000; 20(6C):4727-32. PubMed ID: 11205208
[TBL] [Abstract][Full Text] [Related]
32. hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.
Kim JC; Kim HC; Roh SA; Koo KH; Lee DH; Yu CS; Lee JH; Kim TW; Lee HL; Beck NE; Bodmer WF
Cancer Detect Prev; 2001; 25(6):503-10. PubMed ID: 12132870
[TBL] [Abstract][Full Text] [Related]
33. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
[TBL] [Abstract][Full Text] [Related]
35. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
36. Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening.
Potocnik U; Glavac D; Golouh R; Ravnik-Glavac M
Cancer Genet Cytogenet; 2001 Apr; 126(2):85-96. PubMed ID: 11376800
[TBL] [Abstract][Full Text] [Related]
37. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer.
Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A
J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
39. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.
Deng G; Bell I; Crawley S; Gum J; Terdiman JP; Allen BA; Truta B; Sleisenger MH; Kim YS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):191-5. PubMed ID: 14734469
[TBL] [Abstract][Full Text] [Related]
40. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
